Canidol Historical Research
Our approach to research is the opposite of the traditional approach.
The traditional method of drug discovery starts from a “top down” approach – looking for active compounds, screening them, then gradually following all the steps needed to start a clinical trial.
With Cannabinoids, the safety is already well established, and the use is widespread. The top down approach cannot be successful.
Our approach is to look at the data of what is actually happening in our patients – starting with a wide field of examination and focusing on the most clearly successful areas of treatment.
Our extended groups of practitioners include every professional group from consultant neurologists, paediatricians, rheumatologists, dermatologists, general practitioners, prescribing associated healthcare professions and physiotherapists.
To find out more information about research ongoing in each category, please have a look through our menus.